Inventor

Colette Song

Inventor

Ostfildern, DE

Overview

2020–2021

Patent span

Chemistry

Primary field (CPC C)

Patents· 20 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes18%

C07KPeptides18%

C12NMicroorganisms or enzymes18%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms11%

G01NInvestigating or analysing materials by determining their chemical or physical properties9%

G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology6%

C12YEnzymes2%

PatentTitleYear

11,001,616Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2021 11,001,617Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods2021 10,967,053Peptides and combination of peptides for use in immunotherapy against various cancers2021 10,954,281Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods2021 10,947,286Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2021 10,946,081*03 restricted peptides for use in immunotherapy against cancers and related methods2021 10,946,064Personalized immunotherapy against several neuronal and brain tumors2021 10,925,948Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers2021 10,925,947A*03 restricted peptides for use in immunotherapy against cancers and related methods2021 10,899,812Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods2021 10,899,808Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2021 10,898,560Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers2021 10,899,814Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods2021 10,899,813Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods2021 10,899,811B*44 restricted peptides for use in immunotherapy against cancers and related methods2021 10,898,559Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers2021 10,899,810B*44 restricted peptides for use in immunotherapy against cancers and related methods2021 10,899,807Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2021 10,899,809Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers2021 10,751,359Nucleic acid aptamer specifically binding to avian influenza virus subtype H5 and method of detecting avian ifluenza virus subtype H5 using the same2020

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2020Patents assigned to KOREA INST SCI & TECH (1)· patent assignee history

2020Based in Anyang-si, KR· patent location history

2021Patents assigned to IMMATICS BIOTECHNOLOGIES GMBH (19)· patent assignee history

2021Based in Ostfildern, DE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
IMMATICS BIOTECHNOLOGIES GMBH	19	2021
KOREA INST SCI & TECH	1	2020

Locations

Location	Patents	Span
Ostfildern, DE	19	2021
Anyang-si, KR	1	2020